EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 172 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $318,000 | -30.3% | 6,635 | -33.1% | 0.02% | -39.3% |
| Q1 2020 | $456,000 | -28.1% | 9,920 | -6.0% | 0.03% | +12.0% |
| Q4 2019 | $634,000 | +17.6% | 10,550 | +10.8% | 0.02% | +4.2% |
| Q3 2019 | $539,000 | -42.1% | 9,525 | -43.0% | 0.02% | -33.3% |
| Q2 2019 | $931,000 | -35.3% | 16,725 | -12.1% | 0.04% | +2.9% |
| Q2 2018 | $1,440,000 | +14.1% | 19,030 | -20.6% | 0.04% | +25.0% |
| Q1 2018 | $1,262,000 | -9.1% | 23,955 | -7.9% | 0.03% | 0.0% |
| Q4 2017 | $1,389,000 | -11.0% | 26,005 | -0.7% | 0.03% | -12.5% |
| Q3 2017 | $1,561,000 | – | 26,180 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |